drugset
drugset / Trial / NCT05003687

Safety and Tolerability of Lu AG06474 in Healthy Young Men

NCT05003687 ↗

Phase 1 Completed 79 enrolled H. Lundbeck A/S
RandomizedSequentialDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety and tolerability of Lu AG06474 and what the body does to Lu AG06474 after swallowing single doses of the drug.

Timeline

Start
2021-08-04
Primary completion
2022-12-22
Completion
2022-12-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06474 Unknown — Oral

Indications

No indication recorded.